↓ Skip to main content

Cochrane Database of Systematic Reviews

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

Overview of attention for article published in this source, April 2013
Altmetric Badge

Mentioned by

1 policy source
6 tweeters
1 patent
2 Facebook pages


114 Dimensions

Readers on

115 Mendeley
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Published by
John Wiley & Sons, Ltd, April 2013
DOI 10.1002/14651858.cd000545.pub4
Pubmed ID

Chande, Nilesh, Tsoulis, David J, MacDonald, John K


The results from controlled clinical trials investigating the efficacy of azathioprine and 6-mercaptopurine for the treatment of active Crohn's disease have been conflicting and controversial. An updated meta-analysis was performed to assess the effectiveness of these drugs for the induction of remission in active Crohn's disease.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 3%
Ireland 1 <1%
Norway 1 <1%
Italy 1 <1%
Chile 1 <1%
United States 1 <1%
Unknown 106 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 18%
Student > Ph. D. Student 16 14%
Other 15 13%
Student > Bachelor 13 11%
Student > Postgraduate 11 10%
Other 30 26%
Unknown 9 8%
Readers by discipline Count As %
Medicine and Dentistry 71 62%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Agricultural and Biological Sciences 7 6%
Chemistry 3 3%
Computer Science 3 3%
Other 13 11%
Unknown 11 10%